Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Matrix begins treating patients in phase II study of FMdC

Feb. 26, 1999

Magainin reports interim results of squalamine trial

Feb. 26, 1999

FDA grants priority review status to U.S. Bioscience's sNDA for Ethyol

Feb. 25, 1999

Ilex Oncology initiates phase III trial of DFMO

Feb. 25, 1999

New Lilly SERMs especially useful for breast cancer

Feb. 25, 1999

NCI to conduct phase III trial of pure shark cartilage

Feb. 24, 1999

Orphan Medical launches improved form of busulfan in U.S.

Feb. 24, 1999

U.S. patent extends coverage for Immune Response's TCR vaccine technology

Feb. 24, 1999

Immunomedics and NCI to study new class of anticancer agents

Feb. 24, 1999

NeoPharm and Pharmacia & Upjohn reach licensing agreement for liposomal cancer formulations

Feb. 24, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Latus Bio series A financing supports early-stage programs
BioWorld Science
Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...